Alison Abbott, Senior European Correspondent, Munich
Alison has been with Nature in Germany since 1992, covering European science policy and a variety of scientific topics, mostly in biology. She also contributes to the Books & Arts section. Alison gained her first degree and PhD, both in pharmacology, at the University of Leeds. After a period of postdoctoral research, she spent seven years as editor of Trends in Pharmacological Sciences.
Oliver Amft is the founding director of the Chair of Digital Health at the Friedrich Alexander University Erlangen-Nürnberg (FAU). He received the Dipl.-Ing. (M.Sc.) from Chemnitz Technical University in 1999 and the Dr. sc. ETH (Ph.D.) from ETH Zurich in 2008, both in Electrical Engineering and Information Technology. In 2011, he obtained the university teaching qualification from TU Eindhoven. Until 2004, he was a R&D project manager with ABB, Inc. Oliver Amft was an assistant professor at TU Eindhoven between 2009 and 2013, tenured since 2011. In 2014, he was appointed full professor and established the Chair of Sensor Technology at University of Passau, Faculty of Computer Science and Mathematics. Since 2017, Oliver Amft is a full professor at FAU Erlangen-Nürnberg, Faculty of Medicine. Oliver Amft coordinated European research consortia (GreenerBuildings, iCareNet) and has been a PI in several other European and national projects. Oliver has co-authored over 180 refereed archival research publications on context recognition, biomedical sensor technology, wearable computing, digital health, and embedded systems. Oliver is an Editorial Board member of IEEE Pervasive Computing, co-editing the Wearable Computing department. Oliver is an associate editor for Frontiers in ICT, on Mobile and Ubiquitous Computing (open access), the IEEE Journal of Biomedical and Health Informatics, and the Proceedings of the ACM on Interactive, Mobile, Wearable and Ubiquitous Technologies (IMWUT). He is an member of the IEEE, the IEEE Computer Society, the IEEE Engineering in Medicine and Biology (EMBS) Society, the German Society for Biomedical Engineering (VDE DGBMT), the German Association for Medical Informatics, Biometry and Epidemiology (GMDS), and the IEEE EMBS Wearable Biomedical Sensors and Systems Technical Committee.
As Director of Human Data Science department, she is leading the team responsible for collecting and leveraging data relevant to the medical domain, aiming to generate valuable insights for citizens in collaboration with healthcare professionals. Her team specializes in data analysis and machine learning.
Focusing on data analysis, business intelligence and data warehousing, Evgeniya spent the last 6 years building data-driven organizations. During her time at Project A, a Berlin-based venture capital firm, she worked with over 20 portfolio companies throughout different industries and sizes, supporting them in the development and implementation of data products.
Evgeniya's educational background is in Economics and Mathematics: she studied in Novosibirsk State University in Russia, as well as in Free University of Berlin and in European School of Business in Reutlingen in Germany.
Ralph is a digital health enthusiast and active angel investor and startups mentor in the sector. He gained his financial independence as one of the original founders of Simply Business (London) sold to The Travelers Companies.
Ralph is a trained healthcare M&A banker and worked for investment banks and healthcare companies in the US and Europe. He provides M&A and partnering advice in the healthcare sector with a focus on the digitalization intersection via his firm HealthCare // TransActions Advisors. His angel investment portfolio includes DocDok, CardioCube and Clue as examples in the digital health sector.
He holds an MBA from Columbia University in New York, a BBA from the University of Wisconsin - Madison and lives with his wife in Berlin and Lisbon.
Prof. Dr.-Ing. Bert Arnrich is Professor for Digital Health – Connected Healthcare at the Digital Health Center of the Hasso Plattner Institute.
His research on ubiquitous sensing and computing technologies is directed towards paving the way for transforming healthcare systems from purely managing illness to maintaining wellness everywhere, anytime and for anyone. He has been a PI in several European and national projects. He has co-authored over 120 refereed research publications.
He studied "Informatics in the Natural Sciences" and received the PhD degree Dr.-Ing. for the thesis "Data Mart Based Research in Heart Surgery" from Bielefeld University in 2006. He established and headed the research group Pervasive Healthcare in the Wearable Computing Laboratory at ETH Zurich between 2006 and 2013. He received an EU FP7 Marie Curie Cofound Fellowship in 2013 and was appointed to tenure track professorship at the Computer Engineering Department at Bosporus University until 2017. Between 2017 and 2018 he worked as a Science Manager for Emerging Technologies at Accenture Technology Solutions.
Yan, 45yo Swiss born, has earned a Master in Telecommunications and graduated from IMD Business School. In the first stage of his career, he led several large infrastructures projects for market leaders such as: BMW, ICI, AT&T. In 2000, he became CEO of Urbanet, the first European start-up offering high speed Internet over Cable TV. After a successful company growth and integration within UPC Group (member of Liberty Global), Yan build and run UPC'S national B2B customer services organization (Pre-sales, engineering, support, PMO and Billing).
For the last 16 years, Yan specialized in transformational leadership roles with country, regional and global scope, has driven innovation, revenue growth and lead major transformations in various industries (Telecommunications, Government, Manufacturing & Logistics, Services, Pharma and Medical devices), such as:
- Bringing citizens at the center by driving the Digitalisation of a Swiss government, - Drove the transformations of: global shared service centers (up to 500 People) and country based organizations, focusing on people development and quicker time-to-market for solutions, - Lead large M&A projects, from scouting to full integration, accelerating strategy implementation, - Reaching massive cost savings (170 Mio Euro yearly) by carving out large businesses ( up to 100+ countries with 6,000+ employees) and implementing new operating models. - Driving the transformation of a global medical device manufacturer by establishing new business models through innovation and digitalization, with a patients and care givers centric approach.
In his today's role, Yan is heading Digital Services at Siemens Healtineers.
Andrew Boulle is a Public Health Specialist in the Department of Health of the Western Cape Province of South Africa, and Professor of Public Health Medicine at the University of Cape Town. He is currently responsible for the Provincial Health Data Centre, a consolidated person-level data environment for public sector health services. He leads the African Health Information Exchange initiative, which develops reference implementations of open interoperability solutions in support of the provincial and national health service responses to HIV and tuberculosis.
Prof. Dr. Erwin Böttinger is Professor for Digital Health - Personalized Medicine and Head of Digital Health Center at the Digital Engineering Faculty of the Hasso Plattner Institute (HPI) gGmbH and the University of Potsdam. He is the founding director of the HPI Digital Health Center. From November 2015 to July 2017 Prof. Dr. Böttinger was the CEO of the Berlin Institute of Health Berlin (BIH). Prof. Dr. Böttinger is considered an international expert in personalized medicine and digital health, in particular for his performance as founding director of the Charles Bronfman Institute for Personalized Medicine at the Icahn School of Medicine at Mount Sinai in New York, USA, from 2005 to 2015.
Dr. Jasmin Cirillo studied biology at the Free University of Berlin, majoring in bioacoustics in behavioral biology, graduated in 2003 with a doctorate in social and psychobiological aspects of whispered speech. Until 2009 Postdoc at the Free University of Berlin with projects on nightingale song, bioacoustics in river dolphins in Cambodia in cooperation with the WWF and dialect and social group development in the resettlement of captive killer whales from SeaWorld USA to the Loro Parque Tenerife/Spain. 2010-2015 position as consultant for study and teaching affairs at the medical faculty of Saarland University. 2015 moving from Saarland to Australia and after 2 years sabbatical in Adelaide/South Australia coming home to Berlin. Since January 2018 Program Manager at the Digital Health Center at HPI.
Spiros Denaxas is an Associate Professor in Biomedical Informatics based in the Institute of Health Informatics at University College London. His background is in computer science, information systems engineering and bioinformatics. His research lab (http://denaxaslab.org) operates at the intersection between health research and computer science and focuses on creating and evaluating data-driven methods for transforming electronic health records into research-ready datasets and answering clinically meaningful questions.
Alexander Diehl is a German entrepreneur and digital investor. Since 2018 he has been managing Hasso Plattner Ventures, Hasso Plattner's third Venture Fund with a volume of 150 million euros. The focus of the group is on investments in software and deep tech companies, in particular to expand the European ecosystem of innovative companies and deepen cooperation with companies and medium-sized companies.
In 2011, he initiated BMW i Ventures, the venture investment firm of the BMW Group, and managed it as Managing Director until 2015. After returning to Germany, he remained with the Group until 2017 as a Senior Advisor.
In 2006 he founded the digital agency KKLD * GmbH, which was acquired by WPP plc in 2012 and is now part of the Wunderman (WPP) network. In 2009, together with Marc Kushner, he founded the architecture technology platform Architizer Inc. in New York City - one of the most successful architecture platforms on the Internet worldwide.
Alexander studied at the Royal Academy of Music and at King's College in London - in 1999 he passed his Bachelor of Music (hons) exam.
Hanna Drimalla is a research fellow at the Digital Health Center of the Hasso-Plattner Institute at the University of Potsdam. Her current research focuses on using machine learning technologies to predict and prevent psychological and medical crisis. Hanna holds a master’s degree in psychology from the Ruhr-University of Bochum and a master’s degree in computational science from the University of Potsdam. In the context of her doctoral thesis work, she has been investigating human social interactions using psychological, physiological, and computational methods at Humboldt University in Berlin. In addition to her academic career, she has worked as a freelance science journalist for various magazines.
Dr. Dudley is currently Associate Professor of Genetics and Genomic Sciences and founding Director of the Institute for Next Generation Healthcare at the Icahn School of Medicine at Mount Sinai. In March 2018 Dr. Dudley was named Executive Vice President for Precision Health for Mount Sinai Health System. In 2017 he was awarded an Endowed Professorship by Mount Sinai in Biomedical Data Science. Prior to Mount Sinai, he held positions as Co-founder and Director of Informatics at NuMedii, Inc. and Consulting Professor of Systems Medicine in the Department of Pediatrics at Stanford University School of Medicine. His work is focused at the nexus of -omics, digital health, artificial intelligence (AI), scientific wellness, and healthcare delivery. His work has been featured in the Wall Street Journal, Scientific American, Neuron, MIT Technology Review, CNBC, Today Show and other popular media outlets. He was named in 2014 as one of the 100 most creative people in business by Fast Company magazine. He is co-author of the book Exploring Personal Genomics from Oxford University Press. Dr. Dudley received a BS in Microbiology from Arizona State University and an MS and PhD in Biomedical Informatics from Stanford University School of Medicine.
Dr. Werner Eberhardt is the Global Head of SAP Health.
The SAP Health unit was formed under Werner’s leadership based on the strategy to use SAP HANA, an in-memory data platform, as an enabler for the digital transformation of healthcare. The SAP Health team’s mission is to create innovative solutions for healthcare providers globally; as well as to drive multiple, strategic co-innovation projects and networks with renowned customers and partners. Projects that are empowering them to efficiently run their core businesses and to make data-driven decisions, in real-time to improve care for their patients.
Werner joined SAP in 2004 to establish and lead the global strategic ecosystem marketing organization. He was previously holding management positions at Merck KGaA, Hewlett-Packard and LION Bioscience AG. Among other accomplishments he introduced leading bioinformatics solutions and the world’s first commercial lab-on-a-chip system in collaboration with Caliper Technologies in Palo Alto.
He is based out of the SAP Headquarters in Walldorf. He did his doctorate thesis in protein analytics at the Max Planck Institute for Biochemistry in Martinsried (Germany) and holds a Master’s degree in Business Administration (Executive MBA) from Mannheim Business School (Germany).
Prof. Dr. Roland Eils is founding director of the Digital Health Center at Berlin Institute of Health (Charité, Berlin) and director of the Health Data Science unit at the Medical Faculty of Heidelberg University. Before, he was founding and managing director of Heidelberg University’s Systems Biology center BioQuant and Head of Division "Theoretical Bioinformatics" (B080) at the DKFZ in Heidelberg. His group has delivered significant contributions to the field of cancer genomics and systems biology. Since 2017 Roland Eils is member of the Organizing Committee of the Human Cell Atlas initiative and Coordinator of the HiGH-Med Consortium. He has published over 350 publications cited over 27000 times resulting in an h-index of 82 (source: google scholar).
Alexander Gleiß is a research associate and PhD Candidate at the Chair of Business Informatics and Digitalization of the University of Potsdam (Prof. Pousttchi). His research comprises the digital transformation of companies, industries and the society through the development, combination and exploitation of digital technologies. Especially, he examines the actual and potential impact of digitalization in the insurance industry and the healthcare sector. In addition to his academic activities, he is the project leader of the ERDF-funded project "Digital Solutions made in Brandenburg | digisolBB" on behalf of Ministry for Economic Affairs and Energy of Brandenburg state which aims to foster the diffusion of digital technologies within the healthcare sector.
Ricardo Jardim-Goncalves holds a PhD degree and received his habilitation (Agregação) in Industrial Information Systems by the NOVA University of Lisbon (UNL). He is an Full Professor at the New University of Lisbon, Faculty of Sciences and Technology, and a Principal Investigator at UNINOVA – Instituto de Desenvolvimento de Novas Tecnologia. He has graduated in Computer Science, with MSc in Operational Research and Systems Engineering. His research activities have been focused on Interoperability of Complex Systems. He has been researching in European Commission funded projects during the last 30 years, with more than 200 papers published in conferences, journals and books. He directes GRIS (GRupo para a investigação em Interoperabilidade de Sistemas; Group for Research in Interoperability of Systems) at UNINOVA (Instituto para o Desenvolvimento de Novas Tecnologias), CTS (Centro para as Tecnologias e Sistemas). He has a relevant standardization activity acting as project leader in ISO TC184/SC4.
Isaac (Zak) Kohane
Isaac (Zak) Kohane, MD, PhD is the inaugural Chair of the Department of Biomedical Informatics and the Marion V. Nelson Professor of Biomedical Informatics at Harvard Medical School. He served as co-author of the Institute of Medicine Report on Precision Medicine that has been the template for national efforts. He develops and applies computational techniques to address disease at multiple scales: from whole healthcare systems as “living laboratories” to the functional genomics of neurodevelopment with a focus on autism.
Over the last 30 years, Zak’s research agenda has been driven by the vision of what biomedical researchers could do to find new cures, provide new diagnoses and deliver the best care available if data could be converted more rapidly to knowledge and knowledge to practice. In so doing, Kohane has designed and led multiple internationally adopted efforts to “instrument” the healthcare enterprise for discovery and to enable innovative decision-making tools to be applied to the point of care. At the same time, the new insights afforded by ’omic-scale molecular analyses have inspired him and his collaborators to work on re-characterizing and reclassifying diseases such as autism, rheumatoid arthritis and cancers. In many of these studies, the developmental trajectories of thousands of genes have been a powerful tool in unraveling complex diseases.
In 1987, Zak earned his MD/PhD from Boston University and then completed his post-doctoral work at Boston Children’s Hospital, where he has since worked as a pediatric endocrinologist. He joined the faculty at Harvard Medical School in1992, serving as Director of Countway Library from 2005-2015 and as Co-Director of the Center for Biomedical Informatics during the same period, before it became the Department of Biomedical informatics in July 2015. Zak has published several hundred papers in the medical literature and authored a widely-used book on Microarrays for an Integrative Genomics. He is a member of the Institute of Medicine and the American Society for Clinical Investigation.
Christian Lautner is Co-Founder and Managing Partner at Flying Health which focuses on digital health startups developing Digital Biomarkers & Software-as-a-Drug solutions. Previously, he co-founded one of the first German doctor-rating platforms, imedo.de. Afterwards, he joined qualitaetskliniken.de as CEO to work towards comparability of hospital quality, accessible to everyone via digital devices. Christian has been following his passion for Digital Health and he has more than ten years of experience as an entrepreneur and investor in this sector.
Born on November 25, 1946 in Vienna. Study of chemistry, doctorate MPI for Experimental Medicine and MPI for Biophysical Chemistry (1974), Harvard University, Boston (1974-1978), EMBL, Heidelberg (1978-1987), Imperial Cancer Research Fund, London (1987-1994), Director and Scientific Member at the Max Planck Institute for Molecular Genetics (since 1994), Honorary Professor at the Dept. of Biochemistry, Free University of Berlin. Prof. Lehrach is author of more than 1000 publications and 24 patents, is a fellow of the AAAS, and holds the Ján Jessenius SAS Medal of Honour (2003), the Karl Heinz Beckurts Award (2004) and the Gusi Prize (2015) in recognition of his achievements in medical sciences. He was co-ordinator of ‘ITFoM: IT Future of Medicine’ (www.itfom.eu), a finalist of the FET Flagship Call, which has established a strong technological roadmap and network of partners from 33 countries. In a new initiative, Prof. Lehrach represents a growing network of research institutions, industry representatives, scientists and patient groups that share a long-term vision for sustainable health care (www.futurehealtheurope.eu).
Prof. Lehrach has founded several biotechnology companies such as Sequana Therapeutics, GPC Biotech, Scienion, Prot(at)gen, PSF Biotech, Atlas Biolabs. He is founder of the Berlin-based company Alacris Theranostics GmbH, specialising in the development of new approaches for personalised medicine for cancer patient diagnosis, treatment and drug stratification. He is chairman of the Supervisory Board and scientific advisor of the company since 2008. In 2010 he founded the non-for-profit research institute The Dahlem Centre for Genome Research and Medical Systems Biology (DCGMS).
Prof. Dr. rer. nat. Christoph Lippert is Chair for Digital Health – Machine Learning at the Hasso Plattner Institute (HPI) and the University of Potsdam.
Dr. Lippert is an internationally recognized expert in machine learning and artificial intelligence in medicine and genomics.
After completing his PhD at the Max Planck Institute for Intelligent Systems in Tübingen, working on genome-associated studies in 2012, Dr. Lippert went into industry, as a Researcher at Microsoft Research in L.A., CA, and 2015 as a Data Scientist at Human Longevity, Inc., in Mountain View, CA. After returning to Germany in 2017, to join the the Max Delbrück Center for Molecular Medicine in Berlin as a group leader, he joined the HPI in September 2017.
Dr. Gernot Marx, MD, FRCA is full Professor of Anesthesiology and Critical Care Medicine and Chair at the University RWTH Aachen, Germany. He is Head of the Department of Intensive Care Medicine and Intermediate Care at the University Hospital RWTH Aachen. He is chairman of the board of the German Society of Telemedicine. He is full board member of the German Society of Anaesthesia and Intensive Care and full board member of the interdisciplinary German Society of Intensive Care and Emergency Medicine. Gernot Marx leads the largest German telemedicine project for intensive care and infectiology patients “TELnet@NRW” funded by the “Innovationsfond”. In 2018 he was elected as chair of Innovation centre for digital medicine in Aachen. He graduated and took his residency at the Medizinische Hochschule Hannover in Germany. He was Senior Lecturer in Anaesthesia and Intensive Care Medicine at the University of Liverpool, UK and full Professor for Anaesthesiology, Intensive Care and Emergency Medicine at the Friedrich-Schiller-Universität Jena, Germany. He received the Fellowship by election of the Royal College of Anaesthetists. His research interest is focused on sepsis, fluid therapy and telemedicine. Prof. Marx has published more than 150 peer-reviewed papers. He is Editor of various books, e.g. Checklist Intensive Care Medicine and The Intensive Care Medicine. He is Editor in Chief of intensivup2date, Editor of AINS (Anaesthesiologie Intensivmedizin Notfallmedizin Schmerztherapie) and Associate Editor of British Journal of Anaesthesia.
Oscar Mayora obtained his Ph. D. in Electronic Engineering and Informatics at DIBE, University of Genoa, Italy in 2000. In the same year, he joined the Advance Interactive Systems Laboratory at VTT Electronics in Oulu, Finland, as an ERCIM Visiting Research Fellow.
In August 2001 he was appointed Associate Professor in Computer Science at Tecnológico de Monterrey where he became head of the Graduate Program in Computer Science.
From 2004 – 2016 he was Head of the Ubihealth area at Create-Net. Dr. Mayora is senior member of the ACM and SIG-CHI and was former president of ACM SIG-CHI for Mexico. Dr. Mayora is founder and permanent member of the steering committee of Pervasive Health Conference. He has published over 100 papers in International Conferences and Journals, participated as Guest Editor of special issues of Journals such as IEEE Intelligent Systems, EURASIP Signal Processing, Springer MONET and IMIA Journal on Methods of Information in Medicine in the topic of Pervasive Healthcare.
Dr. Mayora has coordinated research projects at National and International level. He has been involved in projects in the topic of pervasive healthcare and assistive technologies sponsored by different funding instruments such as EC FP6, FP7, H2020 and ICT Labs among others with different roles. As project coordinator in FP6 SAMBA, FP7 MONARCA, NYMPHA PCP and Marie Curie UBIHEALTH Research Network and as participant in H2020 SmartSDK, FiwareMexico, FP7 INTERSTRESS, Rehab@ HOME, NextMedia and other local projects such as Riabiligames, iTheater, The Living Space and Ambient Aware Assistance.
Since January 2017 Dr. Mayora is senior researcher at FBK High Impact Initiative on Health and Wellbeing, Scientific Coordinator of the EIP-AHA Trentino Reference Site on Active and Healthy Ageing, responsible for the Projects coordination of TrentinoSalute4.0 initiative and adjunct professor in the Faculty of Cognitive Sciences at University of Trento.
Dr. Markus Müschenich is a board certified pediatrician and holds a Master degree in Public Health. For more than 10 years he has been a board member of non-profit and private hospital groups. He is founding and board member of the German Association for Internet Medicine and Venture Partner in the investment team of Peppermint Venture Partners.
Dr. Markus Müschenich is Co-Founder and Managing Partner of the Berlin-based Flying Health Incubator which focuses on digital health startups developing Digital Biomarkers & Software-as-a-Drug solutions. Dr. Markus Müschenich is regarded as a specialist for digital medicine of the future. He is active as a speaker at national and international conferences as well as an author.
Andres Metspalu, MD 1976, PhD 1979, postdoc at Colombia University and Yale University in 1981-1982. His main scientific interests are human genomics, genetics of complex diseases and population based biobanks and application of the precision medicine in health care, H-index: 90. 1993-1994 at Baylor College of Medicine, Houston, as a visiting faculty and 2000 at IARC, Lyon, France as a recipient of the International Visiting Senior Scientist Award, in 2012 sabbatical at University of Lausanne. From 1996 to 2008 A. Metspalu was also the head and founder of the Molecular Diagnostic Center of the Tartu University Hospital. Metspalu is the past (2006) president of the European Society of the Human Genetics (ESHG). He is one of the founders and directors of the P3G Consortium of Biobanks (Montreal) and BBMRI-ERIC. 2010 he elected to the Estonian Academy of Sciences. He has supervised over 20 Ph.D. theses. He is serving in several national and international committees (SAC of the Science of Europe), chair of the SC of ESOF2018 and SAB of ESOF2020 editorial boards and has received among other awards and honors the Order of the Estonian Red Cross 3rd Class and L’Ordre des Palmes Academiques from the Republic of France. In 2010, he received the Doctor Honoris Causa from Vilnius University.
Peter Ohnemus is the founder of the dacadoo Health Score/dacadoo ag, Zurich/Switzerland. The patented dacadoo Health Score & Lifestyle Navigation Platform is being licensed to key Life & Health Insurance companies (Payers) and global healthcare operators (Providers).
Peter has been involved in high-tech and bio-tech investments over the last 25 years and this had led to four IPO’s and multiple trade sells. Peter Ohnemus and his private investment firm Network Capital Holding are currently investing in high-tech and bio-tech start-ups. Peter was CEO & co-founded ASSET4 in 2004 with Goldman Sachs and Merrill Lynch as investors (the world’s leading provider of extra-financial information), which was sold to Thomson Reuters, New York in November 2009. Peter Ohnemus previously held senior executive positions with Sybase, Logic Works, The Fantastic Corporation and COS – all of which went public during his tenure. Peter Ohnemus was Entrepreneur of the Year (EoY) for Switzerland by EY. Peter is a frequent speaker and commenter on high-tech and healthcare globally. He has spoken at World Economic Forum (WEF), Fortune Brainstorm Health, Google Tech Talks, McKinsey’s Life Leaders CEO Forum, The Royal Society of Medicine, Stanford LIGHT Conference, CommunicAsia, Mobile World Congress, European Health Forum by the EU, Economist Global Healthcare Forum, Mobile Health Summit DC, European Tech Tour, Red Herring, WWW/Digital Disease Detection, etc. Over the last 10 years Peter has been board member of Rothschild Bank, Tele Denmark (Switzerland), Esbatech, CommerceOne, etc. Peter occasionally teaches digital innovation, entrepreneurship and economic impact at Universities such as HSG - Switzerland, Bocconi - India. Peter lives outside Zürich, is married and has 5 daughters.
Jasper zu Putlitz
Dr. med Jasper zu Putlitz is partner at the private equity company DEDIQ. He serves as deputy chairman of the board of trustees of the Max Planck Institute for Brain Research in Frankfurt and curator of the Max Planck Foundation as well as lecturer at the Hasso Plattner Institute Digital Health Center. As a physician, scientist and manager, he has over 25 years of experience in healthcare. Previously, he was managing director at Accenture, CEO of a US-based home telehealth company and a partner of McKinsey & Company. He has a clinical and science background with roles as research fellow in medicine at Harvard University’s Massachusetts General Hospital Cancer Center as well as resident and fellow at various university hospitals in Germany and Switzerland. Jasper holds a M.D. degree from the University of Munich.
Lonny Reisman, M.D., F.A.C.C., is Founder and Chief Executive Officer of HealthReveal. HealthReveal is a clinical AI company dedicated to mitigating avoidable consequences for patients who suffer from chronic disease. Previously, Lonny served as Aetna's chief medical officer for six years. During his tenure at Aetna he was responsible for the company's clinical strategy to improve the health of Aetna's members and helped build a better healthcare system supported by evidence-based accountability by every participant.
Prior to his CMO position, Lonny was Chief Executive Officer of ActiveHealth Management. He co-founded ActiveHealth Management, now an Aetna subsidiary, following nearly 20 years of experience as a physician and consultant to large employers concerned about healthcare quality and costs. Lonny led the development of the ActiveHealth CareEngine® System, a clinical decision support technology platform that received a U.S. Patent in 2004.
Lonny is a member of the Harvard Medical School Health Care Policy Committee; the New York eHealth Collaborative Board of Directors; the East Coast CMO Executive Summit Committee; the New York City Health and Hospitals Corporation OneCity Health Executive Committee; and the American College of Cardiology Science and Quality Committee. From 1991 to 1998, Lonny was a principal in the Managed Care Group of William M. Mercer where he led numerous consulting engagements with Fortune 500 corporations, healthcare providers, suppliers and payers that focused on managing the demand for healthcare resources.
Lonny was an attending physician at New York Hospital and St. Luke's-Roosevelt Hospital Center between 1987 and 1999, and was a cardiology fellow at the University of Chicago from 1985 to 1987. He received his undergraduate degree from the State University of New York at Stony Brook and his medical degree from Tel Aviv University.
Dr. Ritter holds a full professorship at Charité Berlin and leads the Brain Simulation Section at the Dept. of Neurology. She studied medicine at the Charité and spent a large part of her clinical traineeships and practical year abroad at the universities UCLA and UCSD in Los Angeles and San Diego, the Mount Sinai School of Medicine in New York and the Harvard Medical School in Boston. Dr. Ritter is co-lead of the international consortium TheVirtualBrain. Dr. Ritter particularly focuses on the translational aspect of computational neuroscience and the development of accessible technologies. Her goal is to make brain simulation a powerful and elegant tool for everyone. Doctors can use it for reliable diagnoses and “dry runs” of individual therapies for brain diseases. Students can learn how our brain works. Dr. Ritter’s brain simulation work has spawned popular art installations (myvirtualdream.org) and smartphone apps for neurofeedback (brainmodes.com). Artists work with the mesmerizing visualizations of the brain and participants and users can playfully interact with their real-time “brain avatar”. More than 10 years ago, Dr. Ritter has started an international meeting BrainModes.org taking place annually at locations around the globe. She leads several research consortia including two consortia within the EU flagship the Human Brain Project ‘Co-designing the digital infrastructure of HBP: The Virtual Brain’) and ‘Medical Informatics Platform -Testing pathophysiological models of brain diseases: The Neurodegenerative Virtual Brain’. She also leads the Mill€15 Horizin2020 funded Research and Innovation Action ‘VirtualBrainCloud’ and holds an ERC Consolidator grant. Before entering the arena of brain simulation, Dr. Ritter's work was focused on the role of neural oscillations in health and disease and multimodal brain imaging with a particular focus on brain state dependencies of plasticity and learning. As a result of her group's efforts to understand oscillatory brain dynamics, plasticity and learning it became increasingly clear that computational brain models have the power to provide mechanistic explanations for the physiological processes underlying healthy and aberrant brain activity. Nowadays, the researchers of the Brain Simulation Section are working at the direct intersection between data and theory of the nervous system.
Marieke Rohde works as data scientist and scientific consultant for Robotics and Machine Learning at the Institute for Innovation and Technology, Berlin since 2018. On the panel, she will speak about her previous experience as co-founder of the startup "Affective Signals" (2016-2017), which worked on a depression monitoring system to assess depression severity based on nonverbal signals in video and audio analysis of spoken conversations. Before founding Affective Signals, she studied Cognitive Science, Artificial Intelligence and Computer Science in Osnabrück and Sussex. She did a PhD in Evolutionary Robotics in 2008 and worked for eight years (2008-2016) as postdoctoral researcher in multisensory perception and action in Tübingen and Bielefeld, publishing more than 20 international publications.
Jan Philipp Sachs
Jan Philipp Sachs is a PhD student at the Digital Health Center of the Hasso Plattner Institute at the University of Potsdam. His current research is focussing on the prediction and subsequent prevention of back pain using consumer technology as well as on how Digital Health applications can be deployed in medical practice. As a former CEO of a medical supplier cooperative, he is also interested in the changes healthcare industry and services are undergoing under the premises of digital technologies and is investigating them systematically within the multidisciplinary digisolBB consortium. He has a background in medicine and medical physics, where he received its MD and M.Sc. degrees from the University of Heidelberg.
Lee Stopak is leading the genetics and personalization efforts at Ada Health. Ada is a personal health guide with a symptom assessment functionality that empowers users to learn and make more informed decisions about their health. Powered by a unique reasoning engine and curated medical content, Ada is able to assess clinical conditions with the highest accuracy available. Ada is implementing a number of bioinformatic, statistical, and ML components to create a well-functioning, generalized AI that can incorporate genetic data (amongst other data) to bring high-quality health information to everyone that needs it.
Lee completed his BSc at the University of Maryland, obtaining a Dual Degree in Neurobiology and Physiology and Finance, while also minoring in Spanish. During university he started researching fungal genetics in a mycology and entomology lab, making transgenic fungus to be used for pest control. Following a short research internship at Johns Hopkins, he studied plant genetics for over a year at the Weizmann Institute of Science in Israel, characterizing genes involved in plant metabolism. In 2014, he moved to Berlin to complete an MSc in medical neurosciences at the Charité. He moved from wet-lab to digital research, performing his thesis on clinical data analysis for a rare neurological disease called neuromyelitis optica. During this time, he also completed lab rotations in fMRI and olfaction, analyzing complex datasets with statistical learning techniques. Following the completion of his masters, he began working at Ada in January 2017.
As Research Platform Engineering Director, he and his team have been working closely with the researchers at the Hasso Plattner Institute's Digital Health Centre to develop tools to expedite their research. Moreover, the team has been investigating and implementing technologies and standards in order to promote interoperability within healthcare.
With over 10 years of experience across different industries, Philip has developed software in large companies like J.P. Morgan and eBay, as well as in small startups. With this experience he has learned the importance of scalable software and the technologies and techniques with which to build large robust systems.
Philip studied at the University of Strathclyde in Glasgow where he obtained a first class honours degree in Mathematics and Computer Science. He is passionate about agile software engineering and has been invited to numerous conferences to present his workshop on promoting tester-developer collaboration.
Christian Weiss is Managing Director of HPS Gesundheitscloud gGmbH. His main focus lies on business development and human resources. Furthermore, he is one of the Founding Partners of SUNFISH PARTNERS, a group of entrepreneurs and early-stage investors who love to help strong founders grow their early-stage tech companies into successful businesses. Prior to his work at Gesundheitscloud gGmbH and SUNFISH PARTNERS, Christian already gathered various experiences managing and building up companies in early growth stages:
Co-Founder and former General Partner of Project A Ventures, a Berlin-based operational VC
Co-Founder and former Managing Director (Global; main focus on Latin America) of Rocket Internet and a Co-Founder
Former Managing Director of various startups in the tech- and other spaces including Mundwerk
Finally, Christian has been acting as an active Business Angel in more than 25 startups, e.g., audibene, quandoo, chronext, mycs, and FourSource. Christian holds a B.Sc. & M.Sc. in Management. He studied at WHU, Manchester, and ESC Nantes.
Dr Justin Whatling leads Population Health management for Cerner outside of the USA. He has more than 20 years of experience in healthcare, of which 16 years have been focused on using technology and informatics to transform outcomes for patients.
Justin trained at Kings College London in Medicine with distinction, and has a first class degree in Molecular Biology. He worked as a hospital physician in world-leading centres including Kings College Hospital, Hammersmith Hospital and Queens Square National Hospital of Neurology & Neurosurgery.
Justin is an Independent Member of the NHS’s National Information Board, who set the strategy and direction for the health and care system in England on technology and information.
Justin is a visiting professor in health informatics at University College London in the Faculty of Population Health Sciences and Institute of Digital Health. Justin teaches MSc students studying health informatics, has published with UCL in the field of health related quality of life, and in 2016 established a formal partnership between UCL and Cerner.
He completed in March 2017 his third term of office as a non-executive director of the BMJ Group supporting digitising the evidence base into care provision. In this role he has helped establish group strategy, and new capabilities for health informatics and clinical risk management.
Justin is passionate about developing professionalism for health informatics. He is a Fellow of BCS, The Chartered Institute for IT, the UK professional body for IT. He is immediate past chair for BCS Health where he re-launched their academic journal, established strategy and policy function and expanded support for professionalism in the UK health IT workforce. In 2017 Justin is to join an appointment panel to admit the first 50 Fellows to the new Faculty of Clinical Informatics.
Prior to his role in Cerner, Justin was Clinical Director for the health sector in British Telecommunications Plc leading global strategy, business development, product portfolio as well as clinical functions. Justin held previous roles in Accenture and ran a health outcomes business on behalf of Bupa.
Dr. Emily Wong is an Infectious Disease specialist and translational scientist at the Africa Health Research Institute (AHRI) in Durban, South Africa. Emily specializes in establishing unique human cohorts to address fundamental questions about human infectious immunology. Emily is one of the co-Primary Investigators of Vukuzazi, a population-based health ‘omics platform. Designed to investigate genetic and acquired drivers of health and disease, Vukuzazi will define individual phenotypes using community-based health screening for HIV, TB and non-communicable diseases and collect biosamples to support genomic and transcriptomic study in a population of 30,000 people in the uMkhanyakude district of KwaZulu-Natal. In addition to her resident faculty appointment at AHRI, Emily is a clinically active member of the Division of Infectious Diseases at Massachusetts General Hospital, a Lecturer at Harvard Medical School and an Honorary Clinical Senior Lecturer in the Division of Infection and Immunity at University College London.